Related Experiment Video
Updated: Mar 31, 2026

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Cellular and molecular basis of RV hypertrophy in congenital heart disease
D Iacobazzi1, M-S Suleiman1, M Ghorbel1
1School of Clinical Sciences, Bristol Royal Infirmary, Bristol, UK.
Abstract:
RV hypertrophy (RVH) is one of the triggers of RV failure in congenital heart disease (CHD). Therefore, improving our understanding of the cellular and molecular basis of this pathology will help in developing strategic therapeutic interventions to enhance patient benefit in the future. This review describes the potential mechanisms that underlie the transition from RVH to RV failure. In particular, it addresses structural and functional remodelling that encompass contractile dysfunction, metabolic changes, shifts in gene expression and extracellular matrix remodelling. Both ischaemic stress and reactive oxygen species production are implicated in triggering these changes and will be discussed. Finally, RV remodelling in response to various CHDs as well as the potential role of biomarkers will be addressed.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Pathophysiology of Heart Failure
Cardiomyopathy I: Introduction and Classification

